This inventor holds 1 USPTO granted patent. Top assignee: Powderject Vaccines, Inc.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovations of Michael D. Macklin
Introduction
Michael D. Macklin is an accomplished inventor based in Madison, WI (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant nucleic acid molecules. His work has implications for vaccine development and immune response elicitation.
Latest Patents
Macklin holds a patent for recombinant nucleic acid molecules that encode at least two antigens. This patent describes vectors and compositions containing these molecules. Additionally, it outlines methods for eliciting an immune response using these innovative compositions.
Career Highlights
Michael D. Macklin is associated with Powderject Vaccines, Inc., where he continues to advance his research in vaccine technology. His expertise in recombinant nucleic acids has positioned him as a key figure in the field.
Collaborations
Macklin collaborates with Deborah L. Fuller, enhancing the research and development efforts at Powderject Vaccines, Inc. Their combined expertise contributes to the advancement of innovative vaccine solutions.
Conclusion
Michael D. Macklin's work exemplifies the intersection of innovation and biotechnology, showcasing the potential of recombinant nucleic acid technologies in vaccine development. His contributions are paving the way for future advancements in immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile